The four known members of the KCND/Kv4 channel family encode voltage-gated potassium channels. Recent studies provide evidence that members of the Kv4 channel family are responsible for native, rapidly inactivating (A-type) currents described in heart (I TO ) and neurons (I SA ). In this study, we cloned the human KCND1 cDNA, localized the KCND1 gene to chromosome Xp11.23-p11.3, and determined the genomic structure and tissue-specific expression of the KCND1, KCND2, and KCND3 genes, respectively. The open reading frame of Kv4.1 is 1941 nucleotides long, predicting a protein of 647 amino acids. The deduced protein sequence of Kv4.1 shows an overall identity of 60% with Kv4.2 and Kv4.3L and corresponds to the common structure of voltage-gated potassium channels. KCND1-specific transcripts were detectable in human brain, heart, liver, kidney, thyroid gland, and pancreas, as revealed by Northern blot and RT-PCR experiments. The comparison of the expression patterns of the known Kv4 family members shows subtype specificity with significant overlaps. The KCND gene structures exhibit an evolutionarily conserved exon pattern with a large first exon containing the intracellular N-terminus and the putative membranespanning regions S1 to S5, as well as part of the pore region. The KCND3 gene contains an additional exon of 57 bp, which is not present in the other two KCND genes and gives rise to the C-terminal splice KCND3L variant with an insertion of 19 amino acids.
INTRODUCTION
The KCND family of voltage-gated potassium channels has, so far, four members: KCND1 (Kv4.1), KCND2 (Kv4.2), and two KCND3 splice variants (KCND3S and KCND3L), which were cloned from rat (Blair et al., 1991; Dixon and McKinnon, 1994; Ohya et al., 1997; Serodio et al., 1996; Tsaur et al., 1997) , mouse (Pak et al., 1991; Serodio et al., 1994 ; Genbank Accession Nos. AF107780, AF107781, and AF107782), dog (Dixon et al., 1996) , or human cDNA libraries (Dilks et al., 1999; Kong et al., 1998; Zhu et al., 1999) .
When expressed in vitro in heterologous expression systems, Kv4 subunits form voltage-activated A-type K ϩ channels. They activate at subthreshold membrane potentials and mediate rapidly inactivating, transient outward K ϩ currents (Dilks et al., 1999; Serodio et al., 1994 Serodio et al., , 1996 Zhu et al., 1999) . The properties are similar but not identical to those of native A-type currents recorded from myocardial cells (I TO ) and from the somata of hippocampal neurons (I SA ).
The cardiac transient outward current I TO plays an important role in the early repolarization phase (phase 1) of the ventricular action potential. Northern blot Zhu et al., 1999) , immunohistochemical (Barry et al., 1995) and functional studies using antisense and dominant-negative methods in heterologous expression systems, in native myocytes, and in transgenic mice (Fiset et al., 1997; Johns et al., 1997; Nakamura et al., 1997) collectively support the notion that rodent I TO is mediated by channels that are assembled predominantly from Kv4.2 subunits. In contrast, canine and human I TO channels may not be assembled from Kv4.2 but from Kv4.3 subunits (Dilks et al., 1999; Kong et al., 1998; Zhu et al., 1999) .
Kv4 mRNAs exhibit a distinct, but partially overlapping expression pattern in rat brain (Serodio and Rudy, 1998) . Kv4.2 protein has previously been localized in neurons to somatodendritic compartments (Sheng et al., 1992) , suggesting a role of this channel in postsynaptic signal transduction and dendritic action potential propagation (Hoffman et al., 1997) . By analogy, A-type (I SA ) channels in neurons of human brain may also be assembled from Kv4 subunits. I SA channels might function in the control of cellular excitability and duration of the action potential.
The importance of Kv4-related channels in cardiac physiology and the essential contribution to dendritic action potential propagation suggest that mutations in the KCND genes are correlated with diseases associated with altered cardiac and/or neuronal excitability. In a first step toward the analysis of candidate disorders, we investigated the structures of the KCND genes and their expression in human tissues. The comparison of KCND1 and KCND3 cDNA sequences as well as of the previously cloned KCND2 cDNA sequence (Zhu et al., 1999) with genomic KCND DNA revealed similar exon/intron structures for the three known KCND genes. The data provide a basis for the future analysis of these genes and the possible identification of new disease-causing mutations.
MATERIALS AND METHODS
Cloning of Kv4 cDNAs and genomic DNA. A DNA fragment, encoding the N-terminus and S1-S6 of Kv4.1, was amplified by RT-PCR from poly(A) ϩ mRNA of HEK 293 cells, which had been isolated with the Fasttrack kit (Invitrogen) and reverse-transcribed with a cDNA synthesis system (Gibco BRL). PCR conditions were as follows: 5 min at 95°C (1 cycle), 30 s at 95°C, 30 s at 55°C, 1 min at 72°C (30 cycles), 5% DMSO, PfuTurbo (Stratagene) with primers TGTCTCCAAGCCCCCACCAT (sense) and GCTCCCAGGGCT-TCACTGAAG (antisense). The C-terminus from S6 to the stop codon was contained in EST IMAGp998C13155 (RZPD, Berlin, Germany; Accession No. R19492), which was identified in the NCBI dbEST database with rat KCND1 by similarity search using the program BLAST 2.0 (Altschul et al., 1997) . The insert of EST IMAGp998C13155 corresponds to nt 1405-1944 of the coding sequence of KCND1 and was used as 32 P-radiolabeled probe to screen an EMBL3 genomic library (Clontech) with standard hybridization techniques. Phage DNA from purified clones was prepared using the Lambda Midi kit (Qiagen).
The complete cDNA of KCND2 was also isolated from a human cortex cDNA library (Clontech) as described (Zhu et al., 1999) .
A BLAST similarity search in the NCBI nonredundant nucleotide database (Altschul et al., 1997) with the human KCND2 cDNA yielded two PAC clones. Nucleotides 1-632 of exon 1 of the KCND2 gene were identified on PAC clone DJ1006K12 (Accession No. AC004946). Exons 2-6 of KCND2 reside on PAC clone DJ0797C05 (Accession No. AC004888). Exon 1 and the border to intron I were isolated by a PCR-based strategy. One microgram of human genomic DNA was digested overnight with EcoRI (MBI Fermentas), extracted with phenol/chloroform, precipitated, and subsequently religated in a volume of 10 l for 4 h at room temperature using T4 -DNALigase (MBI Fermentas). A PCR was performed with 1 l of the ligation reaction as template and 50 pmol of exon 1-specific primers (GGTATACCATCGTCACCATG (sense) and AATAAGCACACAG-GTGC (antisense)) (3 min at 94°C for 1 cycle; 30 s at 94°C, 1 min at 58°C, 2 min at 72°C for 30 cycles; 2 min at 72°C for 1 cycle; PfuTurbo (Stratagene)), yielding a 409-bp product. After direct sequencing of the PCR product, the exon 1/intron 1 boundary was confirmed by using primers GGGTGATTGTTAGGACGTTG (sense) and AAA-CAAATGATTTCCCCGGAG (antisense) in a PCR (3 min at 94°C for 1 cycle; 30 s at 94°C, 1 min at 58°C, 2 min at 72°C for 30 cycles; 2 min at 72°C for 1 cycle; PfuTurbo (Stratagene)) with 500 ng of human genomic DNA. Subsequently, the PCR product of 1454 bp was sequenced with the primers also used for PCR.
The human KCND3S splice variant was isolated by standard hybridization techniques from a human cortex cDNA library (Clontech) using rat KCND3 as 32 P-radiolabeled probe. The KCND3L splice variant was amplified from human liver cDNA (see below). The complete KCND3 cDNA was used to screen a human placenta genomic EMBL3 phage library (Clontech) with standard hybridization techniques. Phage DNA from purified clones was prepared using the Lambda Midi kit (Qiagen) . To analyze the exon/intron boundaries of exon 2, 1 g of human genomic DNA was digested overnight with BamHI (MBI Fermentas), extracted with phenol/chloroform, precipitated, and subsequently religated in a volume of 10 l for 4 h at room temperature using T4 -DNA-Ligase (MBI Fermentas). A PCR (5 min at 95°C (1 cycle), 30 s at 95°C, 30 s at 55°C, 3 min at 72°C (30 cycles), 5% DMSO, PfuTurbo (Stratagene)) with exon 2-specific primers (GGATTTACCACCAGAATCAGAG (sense) and AGCAGATGGAGC-CGAAGAT (antisense)), and 1 l from the ligation reaction as template, yielded a 2-kb-fragment. This PCR product was purified and sequenced directly (see below) with the primers used for PCR. The religated BamHI site was found 371 bp 3Ј from the splice donor site of intron I.
Chromosomal localization of the KCND1 gene. The GeneBridge 4 whole-genome radiation hybrid panel (purchased through Research Genetics) was screened by PCR using KCND1-specific primers. PCRs were performed with 25 ng of DNA for each of the 93 hybrid clones and with human and hamster genomic DNA controls. PCR conditions were (Primer GACTTGGAAGAATACGCTGGAC (sense) and Primer TCATGACACTCCGCAGGAAGC (antisense)) 5 min at 95°C for 1 cycle; 45 s at 95°C, 1 min at 59°C, 1 min at 72°C for 30 cycles; 10 min at 72°C for 1 cycle; 10% DMSO; Taq polymerase (Gibco BRL). PCR results were submitted to the Radiation Hybrid Mapping Server at the Whitehead Institute (http://carbon.wi.mit.edu:8000/ cgi-bin/contig/rhmapper.pl). A cut-off of 15 was chosen for the lod score.
Northern blot analysis. Human multiple tissue and brain blots were purchased from Clontech Laboratories Inc. They were hybridized with ␣-32 P-labeled cDNA probes and washed according to the manual supplied. The blots were exposed to Biomax MS films (Kodak) for 3 to 7 days at Ϫ70°C. Probes used as template in the labeling reactions correspond to nt RT-PCR, Southern blotting, and sequencing. Total RNA from different human tissues (see Fig. 4 ) was isolated by centrifugation through a CsCl cushion (Chirgwin et al., 1979) . The RNA concentration was determined using the RiboGreen RNA quantitation kit (Molecular Probes) according to the supplier's instructions.
Total RNA (2 g) was reverse-transcribed in a volume of 20 l using the Superscript II reverse transcriptase (Gibco BRL) and random primers according to the supplier's instructions. One microliter of each RT reaction was subsequently amplified by PCRs, which were performed using Taq polymerase (Gibco BRL) or PfuTurbo (Stratagene) and the PE 480 thermocycler (Perkin-Elmer). The primer sequences and PCR conditions were as follows: KCND1, CCACTT-GCTGCACTGTCTAG (sense), TGTCGCAGTTCAGGTCAAGG (antisense), 5 min at 95°C (1 cycle), 30 s at 95°C, 30 s at 55°C, 30 s at 72°C (30 cycles), 5% DMSO, 1 M betaine, Taq polymerase; KCND2, AGT-TGTGCCTCAGAATTGGG (sense), AACCATTCCGTTTGCTCTGC (antisense), 5 min at 95°C (1 cycle), 30 s at 95°C, 30 s at 53°C, 30 s at 72°C (30 cycles), 5% DMSO, 1 M betaine, Taq polymerase; KCND3, TCCGTGTGGCCAAAACAGGC (sense), ACTCTCCATG-CAGTTCTGCTC (antisense), 5 min at 95°C (1 cycle), 30 s at 95°C, 30 s at 50°C, 30 s at 72°C (30 cycles), 5% DMSO, PfuTurbo. The resulting PCR fragments were electrophoretically separated on 1.5% agarose gels, stained with ethidium bromide, and photographed. The DNA was transferred onto Hybond-N ϩ nylon membrane (Amersham Pharmacia Biotech) and UV-crosslinked. ␣-32 P-labeled cDNA probes were prepared using the Megaprime kit (apbiotech, Freiburg, Germany) and hybridized for 3 to 5 h to the respective membranes, which were subsequently washed under high-stringency conditions (twice with 2ϫ SSC/0.2% SDS at room temperature and twice with 0.2ϫ SSC/0.2% SDS at 65°C) and autoradiographed for 20 to 120 min to Biomax MS films (Kodak). For probes, which served as templates in the labeling reactions, please see Northern Blot Analysis (above).
The Kv4 RT-PCR products were purified using the GFX-PCR purification kit (apbiotech) and sequenced with the BigDye terminator cycle sequencing kit (Perkin-Elmer). The sequence reactions were analyzed on an ABI 377 or a Prism 310 automated sequencer (Perkin-Elmer).
Sequence alignment. The alignment of Kv4 protein sequences was performed with the program Megalign (DNAstar Inc.) using the Clustal algorithm.
Database sequence submission. All sequences isolated in this paper have been deposited with the NCBI GenBank database under the following accession numbers: for KCND1, AF166003, AF166004, AF166005, and AF166006; for KCND2, AF166007 and AF166008; and for KCND3, AF120491, AF166009, AF166010, and AF166011.
RESULTS

Human Kv4 cDNAs and Deduced Protein Sequences
A BLAST search in the NCBI GenBank identified an EST clone (IMAGp998C13155 (RZPD, Berlin; GenBank Accession No. R19492)) (Altschul et al., 1997) that contained a KCND1 cDNA fragment encoding Cterminal amino acids 469 -647 of the predicted Kv4.1 protein. The ORF of KCND1 cDNA was completed by PCR using first-strand HEK 293 cDNA as template. Primer sequences were deduced from genomic sequences. They had been isolated by screening a human genomic phage library using the a.m. EST clone (IMAGp998C13155) as probe (see below and Materials and Methods). The KCND1 ORF is 1941 nucleotides long, predicting a polypeptide of 647 amino acids. According to its hydrophobicity profile, the topology of the predicted human Kv4.1 protein corresponded to the structure of other Shaker-related Kv␣ subunits with six possibly membrane-spanning hydrophobic segments (S1 to S6), a pore domain between S5 and S6 (P-domain) with the K ϩ channel signature motif "GYGD," and intracellular N-and C-termini. The deduced Kv4.1 protein sequence showed 94% identity with the mouse orthologue mShal (Pak et al., 1991) . Unlike most other Kv␣ subunits of the Shaker family, Kv4.1, like Kv4.2 and Kv4.3, does not contain the consensus site NXT/S for N-glycosylation in the S1-S2 linker (Chandy and Gutman, 1995) , or at other sites. KCND3 cDNAs were isolated by screening a human adult cortex gt10 cDNA library with standard hybridization techniques using the 32 P-radiolabeled cDNA of rat KCND3 as probe. In agreement with previous results (Dilks et al., 1999; Kong et al., 1998) , several positive clones were obtained corresponding to two splice variants. The shorter KCND3 transcript contained an ORF of 1903 nucleotides, predicting a Kv4.3S protein sequence of 636 amino acids. The longer transcript contained 57 additional nucleotides within the C-terminus. Thus, the predicted Kv4.3L sequence is 655 amino acids long.
Alignment of the derived Kv4.1, Kv 4.2, and Kv4.3(S,L) protein sequences showed an overall identity of 60% and a homology of 71% (Fig. 1) . As with other Kv subfamilies, the core region with segments S1 to S6 has been highly conserved. Only a few nonconservative amino acid substitutions were found within this region (93% homology and 88% identity). By contrast, the N-terminal sequences within the tetramerization (T) domain (Kreusch et al., 1998; Lee et al., 1994; Shen and Pfaffinger, 1995; Xu et al., 1995) showed an identity of 59%. The C-termini of the Kv4 channels are the least conserved. A Prosite scan of the Kv4 protein sequences predicted several N-and Cterminal conserved sites for possible posttranslational phosphorylation by protein kinases A and C, Ca 2ϩ / calmodulin-dependent protein kinase II, and mitogenactivated (MAP) kinase (Fig. 1) . Some of these sites may be of functional importance for the activity of Kv4 channels.
The Genomic Structure of the KCND1-3 Genes and Chromosomal Localization of KCND1
The exon/intron structures of the KCND genes were elucidated by comparing the KCND1, KCND2, and KCND3 cDNAs with corresponding genomic DNA sequences. Genomic KCND1 DNA was isolated by screening a human genomic EMBL3 phage library (Clontech) with a radiolabeled KCND1 cDNA probe using standard hybridization techniques. We isolated one clone (D1.1) with a genomic DNA insert that encoded the complete ORF of the KCND1 gene. The sequence comparison with the KCND1 cDNA revealed that the KCND1 ORF is composed of six exons ( Fig.  2A) . The first (and largest) exon encodes the N-terminal 374 amino acids including membrane-spanning regions S1-S5 and the first part of the P-domain (see Table 1 ). Interestingly, the exon/intron border lies within the DNA sequence coding for the K ϩ channel signature motif GYGD (Fig. 1) . The Kv4.1 C-terminus was encoded in five KCND1 exons (2-6, Fig. 2A ). The exon sizes varied between 84 and 226 bp and, thus, were considerably smaller than exon 1. Using the GeneBridge 4 whole-genome radiation hybrid panel, we determined the chromosomal localization of the KCND1 gene. It is located between markers WI-5587 and WI-5717 on chromosome Xp11.23-p11.3 (Fig. 2B) .
A BLAST search of the NCBI nonredundant nucleotide database with the human KCND2 cDNA sequence (Zhu et al., 1999) genomic sequence information was contained in the two PAC clones that corresponded to nt 633-1115 of KCND2 cDNA. They were encoded in a separate exon or exon 1 was incomplete. We chose a PCR-based strategy to complete the missing KCND2 sequence from human genomic DNA. For this purpose, the DNA was digested with EcoRI, religated, and used as template in a PCR with primers complementary to exon 1. The primers were directed toward the 5Ј UTR and the exon/ intron border of exon 1, respectively. The PCR produced a 409-bp fragment (see Materials and Methods for details). Its sequence demonstrated that the KCND2 gene contained an exon 1 of size and structure similar to those of the KCND1 gene (Fig. 2A) .
The KCND3 gene was characterized by screening a human genomic EMBL3 phage library with radiolabeled KCND3 cDNA, which was isolated in this study. Three clones (D3.1-3) were identified, each contained fragments of the KCND3 gene, which were characterized by Southern blotting and direct sequencing. Comparison of the genomic KCND3 sequence with that of the KCND3 cDNA revealed that the KCND3 ORF is similar in structure to KCND1 and KCND2 ( Fig. 2A) . Two KCND3 clones (D3.1 and D3.3) contained exon 1. Clone D3.2 contained exons 3-6. Further analyzes showed that the three clones did not contain exon 2 of the KCND3 gene. A similar PCR-based approach, as described above for exon 1 of KCND2, was chosen to FIG. 1. Alignment of three known members of the human (h) KCND (Kv4) channel family. Deduced amino acid sequences of hKv4.1 and hKv4.2 and of the long splice variant hKv4.3L were aligned using the Clustal algorithm of the Megalign (DNAstar Inc.) program. Numbers on the right side refer to the last amino acid residue in each lane. Residues that are identical in at least two of the three sequences are boxed in black; structurally conserved substituted residues are boxed in gray. Putative membrane-spanning domains S1 to S6, as well as the P domain, are marked by a line on top of the sequences. Exon/intron boundaries are indicated by black arrows. Numbers on top of each arrow correspond to the respective KCND gene. The alternatively spliced KCND3 exon L is underlined. Consensus sequences for protein kinases A and C, Ca 2ϩ /calmodulin-dependent protein kinase II, and MAPkinase have been marked by E, F, ᮀ, and ‚, respectively. Numbers in each of these symbols correspond to the respective Kv4 subunit.
obtain the genomic sequence information of exon 2. BamHI-digested and religated human genomic DNA served as template. The primers were located at the 5Ј or 3Ј end of exon 2 and directed toward intron I or II, respectively (see Materials and Methods for details). The sequence of the 2-kb PCR product confirmed the structure and size of exon 2, as predicted.
We have characterized the complete KCND gene structures. Transcription start sites and the lengths of 5Ј UTRs and 3Ј UTRs have not been determined. Nevertheless, the results indicated that the KCND genes may markedly differ in size (Fig. 2A) . The KCND1 ORF is encoded in ϳ5 kb, the KCND2 ORF is encoded in Ͼ130 kb, and the KCND3 ORF is encoded in Ͼ25 kb of genomic DNA. The size differences are due to greatly varying intron lengths in the KCND genes ( Fig. 2A and Table 1 ). By contrast, the number and sizes of KCND exons 1 to 6 are very similar and appear to be evolutionarily conserved. In comparison to KCND1 and KCND2, the KCND3 gene contains an additional exon (exon L in Fig. 2A ) between exons 4 and 5. Exon L is 57 nucleotides long and thus encodes 19 amino acids. Sequence comparison of this exon and the two alternative KCND3 transcripts, which were previously isolated from human (Dilks et al., 1999; Kong et al., 1998) and rat (Ohya et al., 1997) brain or heart, respectively, revealed that this exon is identical with the insertion present in the C-terminus of the longer transcript. The two Kv4 transcripts are therefore generated by alternative splicing of exon L and not by the use of cryptic splice sites within introns IV or V (Fig. 2A) .
Expression Profile of the KCND Transcripts
The expression profiles of KCND channel mRNAs in human tissues are distinct. Northern blot results demonstrated that KCND1 mRNA was present in moderate amounts in almost all tissues analyzed, including brain, heart, liver, kidney, lung, placenta, and pancreas (Fig. 3A, left) . A very weak signal was obtained with skeletal muscle mRNA. In human brain (Fig. 3A , middle and right), the highest KCND1 mRNA levels were found in cerebellum, amygdala, and thalamus, and lower levels were found in cerebral cortex, medulla, spinal cord, putamen caudate nucleus, corpus callosum, hippocampus, substantia nigra, and subthalamic nucleus as well as in occipital, frontal, and temporal lobes. The estimated KCND1 transcript size is ϳ5 kb. This corresponds to a transcript size of ϳ6 kb reported for rat KCND1 (Serodio et al., 1994) . RT-PCR analyzes using KCND1-specific oligonucleotides confirmed the Northern blot results. In addition, the RTPCRs were carried out with cDNA specific for liver, thyroid gland, kidney, and skin fibroblasts. The results showed expression of KCND1 mRNA in the thyroid gland and cultured skin fibroblasts and, very weakly, in peripheral blood leukocytes (Fig. 4A) , consistent with our notion that KCND1 mRNA is widely expressed in the body.
Previous studies have shown a high level of expression of KCND2 mRNA in rodent brain and particularly in rodent heart. However, human multiple tissue Northern blots hybridized with a radiolabeled KCND2 cDNA showed signals only for brain mRNAs (Fig. 3B , see also Zhu et al., 1999) . The estimated KCND2 transcript size was ϳ6.8 kb and thus similar to the reported transcript size of 7 kb for rat KCND2 (Serodio et al., 1994) . Northern blots indicated relatively high levels of KCND2 mRNA in cerebellum, occipital lobe, frontal lobe, putamen, amygdala, substantia nigra, hippocampus, putamen, medulla, and thalamus and lower levels in cerebral cortex, spinal cord, temporal lobe, corpus callosum, and subthalamic nucleus. Using the more sensitive RT-PCR method, KCND2-specific transcripts were detected in brain tissues, but also in total RNA from heart, kidney, thyroid gland, liver, and skin fibroblasts (Fig. 4B) .
The Northern blot results demonstrated that 
CGCCTTGTAA 3Ј UTR
Note. The first and last 10 nucleotides of the exons are given in boldface uppercase letters; the first and last 10 nucleotides of the adjacent intron are shown in lowercase letters. All splice donor and acceptor sites correspond to the gt/ag rule. The number of each intron is given in Roman numerals and the size in bp unless otherwise indicated (n.d., not determined). The name of each exon is followed by the size in bp or kb. The chromosomal localizations were taken from the following references: for KCND1, this study; for KCND2, Zhu et al. (1999) ; and for KCND3, Kong et al. (1998) .
a For the first and last exons the size of the respective coding sequence is given.
KCND3 mRNA was present at relatively high levels in brain and heart, at lower levels in skeletal muscle and liver, and at very low levels in placenta and pancreas (Fig. 3C, left) . In human brain, KCND3-specific transcripts were most abundant in cerebral cortex, but were also detected in cerebellum, medulla, spinal cord, occipital lobe, frontal lobe, temporal lobe, amygdala, caudate nucleus, hippocampus, substantia nigra, and thalamus (Fig.3C, middle and right) . The estimated KCND3 transcript size was 8.5 kb, which is in good agreement with previously published data for rat (Serodio et al., 1994) and human KCND3 (Kong et al., 1998; Tsaur et al., 1997) . Note that the Northern blot results did not differentiate between the two KCND3 splice variants, which differ by only 57 nucleotides. Therefore, we used RTPCRs to investigate the expression profiles of the short versus long KCND3 splice variant (Fig. 4C) . In brain, the long KCND3 transcript was predominantly expressed in thalamus, caudate nucleus, white matter, and epiphysis. The KCND3S transcript was more abundant in frontal cortex, occipital lobe, and cerebellar cortex. Both transcripts were present in almost equal amounts in pons. Outside the brain, the long KCND3 transcript was predominantly detected, except for heart and thyroid gland where both transcripts were present.
Control PCRs with ␤-actin-specific primers and with cDNAs, used in the above-mentioned analyses of KCND mRNA distributions, confirmed the integrity of the cDNAs and showed almost equal amounts of the expected product for all tissues, except for cerebellar white matter and leukocytes, which showed lower ␤-actin signal intensities (data reviewed but not shown). Therefore, the detection sensitivity of our experiments might have been lower in these two tissues.
DISCUSSION
This paper presents a comparative analysis of the structure and expression of the human KCND gene family, which is related to the Drosophila Shal gene. The KCND genes are located on different chromosomes (Table 1) and exhibit a very similar exon pattern. The differences in the observed sizes of the KCND genes are due largely to the varying intron lengths, which, for example, range from 2.1 to Ͼ117 kb for intron I (see Fig. 2A ). Similar findings were recently reported by our laboratory for the three Kv␤ genes KCNA1B, KCNA2B, and KCNA3B (Leicher et al., 1998) encoding the possible membrane-spanning regions S1-S5 and the first part of the P-domain. The exon 1/intron border was found after the first glycine within the K ϩ channel signature motif GYGD (Fig. 1) . This intron has also been found in KCND genes of other mammals and Drosophila (Wang et al., 1999) as well as in genes encoding K ϩ channels with two pore (P) domains in humans (Arrighi et al., 1998) or Caenorhabditis elegans (Wang et al., 1999) . The following exons (2 to 6) encode comparatively small parts of the C-terminal Kv4 protein sequences. The KCND exon pattern contrasts with that of other Shaker-related Kv channel genes. KCNA genes (except KCNA7) contain uninterrupted ORFs (Kalman et al., 1998) . Those of KCNB or KCNC genes are not interrupted by more than one or two introns (Albrecht et al., 1995) .
The expression profiles of the KCND transcripts, as analyzed in this study with human multiple tissue Northern blots and RT-PCR experiments, showed significant overlaps. Therefore, many of the native Kv4 channels will possibly correspond to heterotetramers consisting of Kv4.1, Kv4.2, and Kv4.3(S, L) . In situ hybridization studies in rat brain showed that Kv4.2 and Kv4.3 mRNAs are more abundant and more widely distributed than Kv4.1 (Baldwin et al., 1991; MaleticSavatic et al., 1995; Rudy et al., 1992; Serodio et al., FIG. 4 . RT-PCR analysis of KCND mRNA expression. Total RNA from different human tissues, as indicated on top of each lane, was reverse-transcribed and PCR-amplified with oligonucleotides specific for KCND1 (A), KCND2 (B), and KCND3 (C) (see Materials and Methods). The ethidium bromide-stained agarose gel is shown in the upper part of each panel, the corresponding Southern blot, which was hybridized with the respective ␣-32 P-labeled cDNA probe, is given at the bottom. Numbers on the left side indicate the size of the PCR products. "L" or "S" corresponds to the long or short KCND3 splice variant, respectively. 1996). In comparison, our Northern blot results suggest that KCND2 mRNA is prominently expressed in most human brain areas that were examined. The KCND1 mRNA expression profile in these tissues was quite similar to that of KCND2. KCND3 mRNA, however, was distinctly expressed in several, but not in all, of the brain tissues investigated. Moreover, some brain areas such as thalamus and white matter prominently expressed the L splice variant, while others like frontal and occipital cortex expressed the S splice variant. In human nonbrain tissues, KCND1 shows the most widespread distribution among the transcripts analyzed (Figs. 3A and 4A) . The strong KCND3-specific hybridization signals on Northern blots loaded with poly(A) ϩ mRNA from human heart are in good agreement with results of other groups (Kaab et al., 1998; Kong et al., 1998) . However, in our RT-PCR experiments (Fig. 4C) , we detected both transcripts in almost equal amounts in total RNA isolated from ventricular muscle. This finding differs from data published by Dilks et al. (1999) , who detected only the long transcript in heart. Since I TO current density is not equally distributed throughout the human heart and not even throughout the myocardial wall (Alings and Wilde, 1999; Casis et al., 1998) , the differences observed in the RT-PCR experiments might be caused by the preparation of RNA from different myocardial regions. Interestingly, we detected Kv4-specific transcripts also in nonexcitable tissues like thyroid gland, kidney, liver, or even cultured skin fibroblasts (Fig. 4) . We were also able to detect KCND1-, KCND2-, and KCND3L-specific transcripts in poly(A) ϩ mRNA isolated from HEK293 cells, an embryonal kidney-derived cell line that is widely used for the heterologous expression of K ϩ channels (data not shown). This finding corresponds well with our RT-PCR experiments with human kidney RNA (Fig. 4) .
The deduced human Kv4.2 and Kv4.3 protein sequences were described recently (Dilks et al., 1999; Kong et al., 1998; Zhu et al., 1999) . The human KCND1 cDNA described in this study has a similar size, sequence, and topology. The derived Kv4.1 protein sequence differs from the murine orthologue mShal by 26 nonconservatively exchanged amino acid residues. In comparison, the human and rat Kv4.2 protein sequences differ by 4 amino acids. Almost the same finding applies to Kv4.3 proteins. This sequence conservation argues for important, evolutionarily conserved functions of the Kv4 channels.
When expressed in heterologous expression systems such as Xenopus oocytes, Ltk Ϫ cells or CHO cells, Kv4 channels mediate fast-inactivating transient K ϩ outward currents (Dilks et al., 1999; Dixon et al., 1996; Fiset et al., 1997; Kong et al., 1998; Petersen and Nerbonne, 1999; Serodio et al., 1994 Serodio et al., , 1996 . The properties of currents mediated by Kv4 channels have been correlated with important rapidly inactivating outward currents in the central nervous system (I SA ) and in myocardium (I TO ). I TO is a possible critical determinant of the early repolarization phase (phase 1) of the cardiac action potential. The Kv4.3 protein is thought to be the molecular correlate of the I TO currents observed in human myocardium and might be associated with specific disease states such as heart failure, hypertension, or arrhythmias such as the long QT syndrome (Alings and Wilde, 1999; Barry et al., 1998; Janse and Wilde, 1998; Johns et al., 1997; Kaab et al., 1998; Takimoto et al., 1997; Wickenden et al., 1998) .
I SA has been recorded from somatodendritic localizations of many neurons in rodent brain. It apparently represents a major determinant of excitability in dendrites of CA1 pyramidal neurons and is thought to have an important influence on dendritic signal integration, underlying processes such as long-term potentiation, learning, and memory Hoffman et al., 1997) . The gating behavior of I SAchannels is comparable to that of Kv4 channels expressed in heterologous expression systems (Jerng et al., 1999) . Furthermore, immunohistochemical studies provided evidence that the Kv4.2 protein is localized to somatodentritic compartments of rat neurons (Serodio and Rudy, 1998; Sheng et al., 1992) . By analogy, Kv4 channels might conduct I SA in neurons of human brain. The overlapping expression profiles of KCND mRNAs in human brain suggest that neurons may express different Kv4 subunits. Thus, the Kv4 channels may consist of heteromultimers being assembled from different Kv4 subunits.
The elucidation of the genomic structure of the KCND genes provides the basis for the analysis of patients with possible alterations in these genes, as might be the case in cardiac arrhythmias, which cannot be attributed to mutations in the "classical" LQT genes or the recently identified KCNE2 subunit (Abbott et al., 1999) . Mutations in the KCND genes might also cause neurological disorders of hitherto unknown etiology, affecting, for example, learning and memory or sensory input. It should be noted in this context that the KCND2 gene maps to a chromosomal region that has been linked to a form of autosomal recessively inherited deafness (Greinwald et al., 1998) or autism (International Molecular Genetic Study of Autism Consortium, 1998) KCND2 is thus a good candidate for causing a new channelopathy. Further analyses are necessary and are currently being performed to clarify the physiological role of these channels.
